Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $62,891.00 |
|---|---|
| Enterprise Value | $-4,667,109.00 |
| Earnings per Share | $-0.09 |
| Beta | 0.95 |
| Outstanding Shares | 57,173,760 |
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.08 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -4.52 |
| Enterprise Value to EBIT | 0.43 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.07 |
| Debt to Equity | 0.14 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
ReNeuron Group plc is a UK-based biotechnology firm dedicated to the discovery, advancement, and eventual market launch of cutting-edge cell-based medical treatments. Their current pipeline features a CTX stem cell therapy, designed to i...